logo

Y-Mabs Therapeutics, Inc. (YMAB)



Trade YMAB now with
  Date
  Headline
10/23/2018 9:21:44 AM Naxitamab Gets Positive Opinion For Orphan Medicinal Product Designation Approval In The EU